Phenotyping Services

In 2012, GemPharmatech joined the International Mouse Phenotyping Consortium (IMPC), and in 2013, we completed the creation of an international phenotyping platform that meets international standards.

The standard analysis process begins at 9.5 days of embryonic development for phenotypic screening of mice. It continues up to 16 weeks, encompassing twenty major tests of cardiovascular, five senses, energy metabolism, bone, neurobehavior, blood biochemistry, blood cells, histomorphology, and others. Based on the phenotype analysis platform and self-developed novel models (such as severe immunodeficient NCG mice and immune checkpoint humanized mice), we have developed a phenotype analysis service system that includes tumor, metabolism, and overall phenotype screening and pharmacological pathology.


GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.